3,5,5-Trimethyl-1,3-thiazolidine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: 3,5,5-Trimethyl-1,3-thiazolidine
• 化学式: C₆H₁₃NS
• 分子量: 131.24
• InChiKey: MUKCQJREHIESPC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  28.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] PESTICIDAL HETEROCYCLIC COMPOUNDS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES PESTICIDES
  申请人：BAYER CROPSCIENCE AG

  公开号：WO2011051455A1

  公开（公告）日：2011-05-05

  The present invention relates to novel pesticidal azolidine derivatives as well as to oxazolidinone derivatives and their use as pesticides for combating animal parasites which occur in the agrochemical field and in the field of veterinary medicine, respectively. Formula (I) wherein X, m, R', Q, G, U, 1, A1 to A4 and R are as defined herein.

  本发明涉及新型杀虫杀虫剂氮杂环丙烷衍生物，以及噁唑烷酮衍生物及其作为农药用于对抗农业化学领域和兽医学领域中出现的动物寄生虫的用途。式（I）中X、m、R'、Q、G、U、1、A1至A4和R如本文所定义。
• Pesticidal Heterocyclic Compounds
  申请人：Murata Tetsuya

  公开号：US20110152332A1

  公开（公告）日：2011-06-23

  The present invention relates to novel pesticidal azolidine derivatives as well as to oxazolidinone derivatives and their use as pesticides for combating animal parasites which occur in the agrochemical field and in the field of veterinary medicine, respectively. wherein X, m, R′, Q, G, U, l, A 1 to A 4 and R are as defined herein.

  本发明涉及新型杀虫的氮杂环丙烷衍生物，以及噁唑烷衍生物，它们可以作为农药用于防治出现在农业化学领域和兽医学领域中的动物寄生虫。其中X，m，R'，Q，G，U，l，A1至A4和R的定义如本文所述。
• Inhibitors of caspases
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：EP2261232A2

  公开（公告）日：2010-12-15

  The present invention relates to novel classes of compounds which are caspase inhibitors, in particular interleukin-1β converting enzyme ("ICE") inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting caspase activity and consequently, may be advantageously used as agents against interleukin-1- ("IL-1"), apoptosis-, interferon-γ inducing factor-(IGIF), or interferon-γ-("IFN-γ") mediated diseases, including inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases. This invention also relates to methods for inhibiting caspase activity and decreasing IGIF production and IFN-γ production and methods for treating interieukin-1, apoptosis-, and interferon-γ mediated diseases using the compounds and compositions of this invention. This invention also relates to methods of preparing the compounds of this invention.

  本发明涉及一类新型化合物，它们是 Caspase 抑制剂，特别是白细胞介素-1β 转换酶（"ICE"）抑制剂。本发明还涉及包含这些化合物的药物组合物。本发明的化合物和药物组合物特别适用于抑制 caspase 活性，因此可作为抗白细胞介素-1-（"IL-1"）、细胞凋亡、干扰素-γ 诱导因子（IGIF）或干扰素-γ-（"IFN-γ"）介导的疾病的药物，包括炎症性疾病、自身免疫性疾病、破坏性骨疾病、增殖性疾病、传染性疾病和退行性疾病。本发明还涉及抑制 Caspase 活性、减少 IGIF 生成和 IFN-γ 生成的方法，以及使用本发明化合物和组合物治疗白细胞介素-1、细胞凋亡和干扰素-γ 介导的疾病的方法。本发明还涉及制备本发明化合物的方法。
• HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
  申请人：KOWALCZYK James J.

  公开号：US20120309938A1

  公开（公告）日：2012-12-06

  The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R 1 -R 7 , X 1 , X 2 , R, Q, and n are as defined herein.